Haicheng Tang

601 total citations
25 papers, 404 citations indexed

About

Haicheng Tang is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Haicheng Tang has authored 25 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Epidemiology. Recurrent topics in Haicheng Tang's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Haicheng Tang is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Haicheng Tang collaborates with scholars based in China and United States. Haicheng Tang's co-authors include Zeyi Liu, Yuanyuan Zeng, Jianjie Zhu, Wenwen Du, Jian‐An Huang, Zongli Ding, Xueting Wang, Yang Zhang, Shu Song and Zhe Lei and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Sensors.

In The Last Decade

Haicheng Tang

23 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haicheng Tang China 12 274 176 60 53 50 25 404
Maojun Di China 6 240 0.9× 137 0.8× 101 1.7× 34 0.6× 52 1.0× 16 353
Surender K. Sharawat India 11 234 0.9× 165 0.9× 102 1.7× 53 1.0× 32 0.6× 33 394
Yeqing Zou China 12 363 1.3× 259 1.5× 43 0.7× 33 0.6× 88 1.8× 18 488
Harekrushna Panda India 11 318 1.2× 222 1.3× 60 1.0× 78 1.5× 32 0.6× 16 549
Xing Xiao China 9 209 0.8× 121 0.7× 50 0.8× 50 0.9× 42 0.8× 22 326
Erik Lizárraga-Verdugo Mexico 7 185 0.7× 156 0.9× 72 1.2× 23 0.4× 27 0.5× 16 291
Shannalee R. Martinez United States 11 243 0.9× 91 0.5× 43 0.7× 54 1.0× 72 1.4× 18 403
Ping Zhan China 10 271 1.0× 213 1.2× 97 1.6× 39 0.7× 88 1.8× 27 463
Rongjun Cui China 13 309 1.1× 229 1.3× 108 1.8× 54 1.0× 55 1.1× 27 440
Veronika Holubeková Slovakia 13 241 0.9× 197 1.1× 93 1.6× 62 1.2× 48 1.0× 32 469

Countries citing papers authored by Haicheng Tang

Since Specialization
Citations

This map shows the geographic impact of Haicheng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haicheng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haicheng Tang more than expected).

Fields of papers citing papers by Haicheng Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haicheng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haicheng Tang. The network helps show where Haicheng Tang may publish in the future.

Co-authorship network of co-authors of Haicheng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Haicheng Tang. A scholar is included among the top collaborators of Haicheng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haicheng Tang. Haicheng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Ping, et al.. (2025). Recurrent Pulmonary Infection Caused by Schizophyllum commune: A Case Report and Management of Inflammation. Respirology Case Reports. 13(7). e70239–e70239.
2.
Wang, Lei, Li Liu, Yun Shen, et al.. (2025). Differential composition of the pulmonary microbiome in HIV-positive versus HIV-negative patients with Pneumocystis jirovecii. PLoS ONE. 20(10). e0334220–e0334220.
3.
Liu, Zhongxiang, et al.. (2024). PERP May Affect the Prognosis of Lung Adenocarcinoma by Inhibiting Apoptosis. Cancer Management and Research. Volume 16. 199–214. 2 indexed citations
4.
Song, Shu, et al.. (2023). circANKRD28 inhibits cisplatin resistance in non‐small‐cell lung cancer through the miR‐221‐3p/SOCS3 axis. The Journal of Gene Medicine. 25(4). e3478–e3478. 13 indexed citations
5.
Xuan, Yan, et al.. (2023). Current status and future of anti-angiogenic drugs in lung cancer. Clinical and Experimental Medicine. 23(6). 2009–2023. 5 indexed citations
6.
Zhu, Zhuxian, Qiang Tang, Yin‐Yuan Mo, et al.. (2023). Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection. BMC Pulmonary Medicine. 23(1). 177–177. 3 indexed citations
7.
Zhang, Xiaolin, Qingguo Wu, Lei Wang, et al.. (2023). Single-cell analysis reveals changes in BCG vaccine-injected mice modeling tuberculous meningitis brain infection. Cell Reports. 42(3). 112177–112177. 11 indexed citations
8.
Liu, Zhongxiang, et al.. (2022). Prognosis-related autophagy genes in female lung adenocarcinoma. Medicine. 101(1). e28500–e28500. 16 indexed citations
9.
Song, Shu, et al.. (2022). LncRNA BCYRN1 promotes cell migration and invasion of non-small cell lung cancer via the miR-30b-3p/ROCK1 axis. Neoplasma. 69(3). 583–593. 4 indexed citations
10.
Song, Shu, Haicheng Tang, Wenqiang Quan, Anquan Shang, & Chunhua Ling. (2022). Estradiol initiates the immune escape of non-small cell lung cancer cells via ERβ/SIRT1/FOXO3a/PD-L1 axis. International Immunopharmacology. 107. 108629–108629. 19 indexed citations
11.
Tang, Haicheng, et al.. (2022). Measles-Associated Severe Pneumonia in a Patient with HBeAg-Negative Chronic Hepatitis B: A Case Report. SHILAP Revista de lepidopterología. 2(1). 5 indexed citations
12.
Li, Feng, et al.. (2022). Risk Factors and Mental Health Status in Patients With Non-Tuberculous Mycobacterial Lung Disease: A Single Center Retrospective Study. Frontiers in Public Health. 10. 912651–912651. 8 indexed citations
13.
Tang, Haicheng, Pei Pang, Qin Zhu, et al.. (2021). The CPNE Family and Their Role in Cancers. Frontiers in Genetics. 12. 689097–689097. 21 indexed citations
14.
Tang, Haicheng, Xiaolin Zhang, Lei Pan, et al.. (2021). Analysis of pathogens and risk factors of secondary pulmonary infection in patients with COVID-19. Microbial Pathogenesis. 156. 104903–104903. 10 indexed citations
15.
16.
Du, Wenwen, Ting Liu, Yang Zhang, et al.. (2020). MiR-195-5p is a Potential Factor Responsible for CPNE1 Differential Expression between Subtypes of Non-Small Cell Lung Cancer. Journal of Cancer. 11(9). 2610–2620. 15 indexed citations
17.
Zhang, Xiaolin, Qian Zhang, Qingguo Wu, et al.. (2020). Integrated analyses reveal hsa_circ_0028883 as a diagnostic biomarker in active tuberculosis. Infection Genetics and Evolution. 83. 104323–104323. 17 indexed citations
18.
Du, Wenwen, Haicheng Tang, Zhe Lei, et al.. (2019). miR-335-5p inhibits TGF-β1-induced epithelial–mesenchymal transition in non-small cell lung cancer via ROCK1. Respiratory Research. 20(1). 225–225. 57 indexed citations
19.
Tang, Haicheng, Jianjie Zhu, Wenwen Du, et al.. (2018). CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 131–131. 58 indexed citations
20.
Zeigler, Mary E., Yiqing Chi, Daniel B. Tumas, et al.. (2001). Anti-CD11a Ameliorates Disease in the Human Psoriatic Skin–SCID Mouse Transplant Model: Comparison of Antibody to CD11a with Cyclosporin A and Clobetasol Propionate. Laboratory Investigation. 81(9). 1253–1261. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maojun Di Breakdown of academic impact, for papers by Surender K. Sharawat Breakdown of academic impact, for papers by Yeqing Zou Breakdown of academic impact, for papers by Harekrushna Panda Breakdown of academic impact, for papers by Xing Xiao Breakdown of academic impact, for papers by Erik Lizárraga-Verdugo Breakdown of academic impact, for papers by Shannalee R. Martinez Breakdown of academic impact, for papers by Ping Zhan Breakdown of academic impact, for papers by Rongjun Cui Breakdown of academic impact, for papers by Veronika Holubeková
Rankless by CCL
2026